Cervarix (HPV2)

Question 1

TYPE:

Answer 1

Inactive

Question 2

ROUTE:

Answer 2

IM

Question 3

INDICATIONS:

Answer 3

Girls and women 9 through 26 years (ACIP) of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types included in the vaccine:

• • Cancer (cervical) caused by HPV types 16 and 18
• • Precancerous or dysplastic lesions (cervical) caused by HPV types 16 and 18

Question 4

DOSE:

Answer 4

0.5 mL

Question 5

OF DOSES:

Answer 5

3 doses

Question 6

FREQUENCY:

Answer 6

Give to girls at age 11–12 years on a 0, 1–2, and 6 month schedule. May be given as early as age 9 years.

For all girls who were not previously vaccinated through age 26 years (ACIP), give 3 ‐ dose series (0, 2, 6 month schedule)

Minimum intervals between doses:

• • 4 wks between #1 and #2
• • 12 wks between #2 and #3
• • at least 24 wks between doses #1 and #3.

If possible, use the same vaccine product for all doses

Question 7

CONTRAINDICATIONS:

Answer 7

Hypersensitivity, including severe allergic reactions to any component or a previous dose of the vaccine

Question 8

PRECAUTIONS:

Answer 8

A) Moderate or severe acute illness with or without fever
B) Pregnancy
C) Syncope ‐ because vaccinees may develop syncope, sometimes resulting in falling with injury, observation for 15 minutes after administration is recommended.
D) Syringes = possible latex

Question 9

ADVERSE REACTIONS:

Answer 9

Injection Site: pain, swelling, erythema, pruritus, and bruising

Systemic: syncope, headache, fever, nausea, and dizziness